Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 24

1.

Impact of the training on the compliance and persistence of weekly bisphosphonate treatment in postmenopausal osteoporosis: a randomized controlled study.

Tüzün Ş, Akyüz G, Eskiyurt N, Memiş A, Kuran B, İçağasıoğlu A, Sarpel T, Özdemir F, Özgirgin N, Günaydın R, Cakçı A, Yurtkuran M.

Int J Med Sci. 2013 Nov 20;10(13):1880-7. doi: 10.7150/ijms.5359. eCollection 2013.

PMID:
24324365
[PubMed - in process]
Free PMC Article
2.

Bisphosphonates for the treatment of osteoporosis: insights for clinicians.

Lewiecki EM.

Ther Adv Chronic Dis. 2010 May;1(3):115-28. doi: 10.1177/2040622310374783.

PMID:
23251734
[PubMed]
Free PMC Article
3.

A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year data.

McClung MR, Benhamou CL, Man Z, Tlustochowicz W, Zanchetta JR, Eusebio R, Balske AM, Matzkin E, Olszynski WP, Recker R, Delmas PD.

Calcif Tissue Int. 2013 Jan;92(1):59-67. doi: 10.1007/s00223-012-9668-4. Epub 2012 Nov 13.

PMID:
23150144
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Medical treatment of osteoporotic vertebral fractures.

Langdahl BL, Harsløf T.

Ther Adv Musculoskelet Dis. 2011 Feb;3(1):17-29. doi: 10.1177/1759720X10392105.

PMID:
22870463
[PubMed]
Free PMC Article
5.

Efficacy of ibandronate: a long term confirmation.

Di Munno O, Delle Sedie A.

Clin Cases Miner Bone Metab. 2010 Jan;7(1):23-6.

PMID:
22461287
[PubMed]
Free PMC Article
6.

Implementing adherence to osteoporosis treatments.

Gonnelli S, Masi L, Brandi ML, Nuti R.

Clin Cases Miner Bone Metab. 2009 Sep;6(3):193-6.

PMID:
22461245
[PubMed]
Free PMC Article
7.

Efficacy and safety of monthly 150 mg oral ibandronate in women with postmenopausal osteoporosis: a systematic review and meta-analysis of randomized controlled trials.

Lee YH, Song GG.

Korean J Intern Med. 2011 Sep;26(3):340-7. doi: 10.3904/kjim.2011.26.3.340. Epub 2011 Sep 13. Review.

PMID:
22016595
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency.

Keshavarzian A, Mayer L, Salzberg B, Garone M, Finkelstein W, Cappa J, Brand M, Hain J, Zelinger D, Hegedus R, Diamond RH, Campbell U, Lane C, Stang P, Watson J, Cominelli F.

Gastroenterol Hepatol (N Y). 2007 May;3(5):381-90.

PMID:
21960854
[PubMed]
Free PMC Article
9.

Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.

Dalle Carbonare L, Zanatta M, Gasparetto A, Valenti MT.

Drug Healthc Patient Saf. 2010;2:121-37. doi: 10.2147/DHPS.S6285. Epub 2010 Aug 19.

PMID:
21701624
[PubMed]
Free PMC Article
10.

Zoledronic acid infusion for prevention and treatment of osteoporosis.

Sunyecz JA.

Int J Womens Health. 2010 Oct 14;2:353-60. doi: 10.2147/IJWH.S7322.

PMID:
21151682
[PubMed]
Free PMC Article
11.

Adherence and occurrence of fractures after switching to once-monthly oral bisphophonates.

Briesacher BA, Andrade SE, Harrold LR, Fouayzi H, Yood RA.

Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1233-40. doi: 10.1002/pds.2048. Epub 2010 Oct 28.

PMID:
21108489
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale, long-term retrospective study in The Netherlands.

Netelenbos JC, Geusens PP, Ypma G, Buijs SJ.

Osteoporos Int. 2011 May;22(5):1537-46. doi: 10.1007/s00198-010-1372-5. Epub 2010 Sep 14.

PMID:
20838773
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Oral bisphosphonate compliance and persistence: a matter of choice?

Silverman SL, Schousboe JT, Gold DT.

Osteoporos Int. 2011 Jan;22(1):21-6. doi: 10.1007/s00198-010-1274-6. Epub 2010 May 11. Review.

PMID:
20458571
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Adoption of once-monthly oral bisphosphonates and the impact on adherence.

Briesacher BA, Andrade SE, Harrold LR, Fouayzi H, Yood RA.

Am J Med. 2010 Mar;123(3):275-80. doi: 10.1016/j.amjmed.2009.05.017.

PMID:
20193837
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women.

Chung YS, Lim SK, Chung HY, Lee IK, Park IH, Kim GS, Min YK, Kang MI, Chung DJ, Kim YK, Choi WH, Shong MH, Park JH, Byun DW, Yoon HK, Shin CS, Lee YS, Kwon NH.

Calcif Tissue Int. 2009 Nov;85(5):389-97. doi: 10.1007/s00223-009-9294-y. Epub 2009 Oct 9.

PMID:
19816648
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review.

Gleeson T, Iversen MD, Avorn J, Brookhart AM, Katz JN, Losina E, May F, Patrick AR, Shrank WH, Solomon DH.

Osteoporos Int. 2009 Dec;20(12):2127-34. doi: 10.1007/s00198-009-0976-0. Epub 2009 Jun 5. Review.

PMID:
19499273
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis.

Cotté FE, Fardellone P, Mercier F, Gaudin AF, Roux C.

Osteoporos Int. 2010 Jan;21(1):145-55. doi: 10.1007/s00198-009-0930-1. Epub 2009 May 21.

PMID:
19459025
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

A blinded randomized controlled trial of motivational interviewing to improve adherence with osteoporosis medications: design of the OPTIMA trial.

Solomon DH, Gleeson T, Iversen M, Avorn J, Brookhart MA, Lii J, Losina E, May F, Patrick A, Shrank WH, Katz JN.

Osteoporos Int. 2010 Jan;21(1):137-44. doi: 10.1007/s00198-009-0951-9. Epub 2009 May 13.

PMID:
19436935
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Adherence to osteoporosis treatments: room for improvement.

Warriner AH, Curtis JR.

Curr Opin Rheumatol. 2009 Jul;21(4):356-62. doi: 10.1097/BOR.0b013e32832c6aa4. Review.

PMID:
19412103
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk